In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature (Q46886695)

26 December 2017

title

In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature (English)

1 reference

26 December 2017

author name string

Wenhui Ma

1

1 reference

26 December 2017

Guoquan Li

2

1 reference

26 December 2017

Jing Wang

3

1 reference

26 December 2017

Weidong Yang

4

1 reference

26 December 2017

Yingqi Zhang

5

1 reference

26 December 2017

Peter S Conti

6

1 reference

26 December 2017

Kai Chen

7

1 reference

26 December 2017

publication date

3 September 2014

1 reference

26 December 2017

published in

Amino Acids

1 reference

26 December 2017

volume

46

1 reference

26 December 2017

issue

12

1 reference

26 December 2017

page(s)

2721-2732

1 reference

26 December 2017

Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging.

cites work

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

CD13/APN is activated by angiogenic signals and is essential for capillary tube formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Angiogenesis in life, disease and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Design and development of molecular imaging probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Positron Emission Tomography Imaging of Cancer Biology: Current Status and Future Prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Target-specific delivery of peptide-based probes for PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

PET imaging of αvβ₃ integrin expression in tumours with ⁶⁸Ga-labelled mono-, di- and tetrameric RGD peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Advancement in the research on vascular endothelial growth inhibitor (VEGI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Design, synthesis, and evaluation of original carriers for targeting vascular endothelial growth factor receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

VEGI, a new member of the TNF family activates nuclear factor-kappa B and c-Jun N-terminal kinase and modulates cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

VEGI-192, a new isoform of TNFSF15, specifically eliminates tumor vascular endothelial cells and suppresses tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Rapid and Simple One-Step F-18 Labeling of Peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Theranostics: Combining Imaging and Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

New strategies for fluorescent probe design in medical diagnostic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Near-infrared fluorescence imaging of CD13 receptor expression using a novel Cy5.5-labeled dimeric NGR peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

High-yield expression, purification and characterization of tumor-targeted IFN-alpha2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Detection of vascular endothelial growth factor in colon cancer xenografts using bevacizumab based near infrared fluorophore conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

CD13/APN regulates endothelial invasion and filopodia formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Crucial role for interferon gamma in the synergism between tumor vasculature-targeted tumor necrosis factor alpha (NGR-TNF) and doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Protein production by auto-induction in high density shaking cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

In vivo imaging of beta-galactosidase activity using far red fluorescent switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

In vivo optical imaging of CD13/APN-expression in tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Molecular imaging in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

In vivo imaging of tumors with protease-activated near-infrared fluorescent probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Characterization of cis-regulatory elements of the vascular endothelial growth inhibitor gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Radiolabeled nanoparticles for multimodality tumor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Modulation of endothelial cell growth arrest and apoptosis by vascular endothelial growth inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Aminopeptidase N/CD13 targeting fluorescent probes: synthesis and application to tumor cell imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

In vivo type 2 cannabinoid receptor-targeted tumor optical imaging using a near infrared fluorescent probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

Emerging roles of proteases in tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00726-014-1828-6

10.1007/S00726-014-1828-6

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017